Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Clinical Genetics, |
RCV002226879 | SCV002505772 | uncertain significance | Brittle cornea syndrome 1 | 2021-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002382480 | SCV002689685 | uncertain significance | Cardiovascular phenotype | 2022-12-04 | criteria provided, single submitter | clinical testing | The p.G3424S variant (also known as c.10270G>A), located in coding exon 2 of the ZNF469 gene, results from a G to A substitution at nucleotide position 10270. The glycine at codon 3424 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and serine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003101292 | SCV003490364 | uncertain significance | not provided | 2022-10-26 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 3424 of the ZNF469 protein (p.Gly3424Ser). This variant is present in population databases (rs548646578, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of ZNF469-related conditions (PMID: 28622062). ClinVar contains an entry for this variant (Variation ID: 1679282). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV003101292 | SCV004184602 | uncertain significance | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | ZNF469: PM2, BP4 |